The Board of Directors in its Meeting held on February 19, 2018 has inter alia, approved the additional investment not exceeding MYR 300,000 (Malaysian Ringgit Three Hundred Thousand), in one or more tranches, in shares of Advanced Enzymes (Malaysia) Sdn. Bhd., Subsidiary (80%) [AEM] in the following manner:
(a) Acquisition of remaining 20% stake i.e. 50,000 equity shares of face value of MYR 1 each from the existing other shareholders of AEM. On completion of the said acquisition, AEM would become wholly owned subsidiary (100%) of the Company; and
(b) Balance investment by way of subscription, purchase or otherwise of shares of AEM, in one or more tranches.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
